Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former Boston unit renamed Navilyst

This article was originally published in Clinica

Executive Summary

Boston Scientific's former fluid management and vascular access businesses, which it sold to private equity firm Avista Capital Partners in February, has taken on the new name Navilyst Medical. The 800-strong, Marlborough, Massachusetts-based company manufactures implantable vascular access devices and products that control fluid levels and monitor pressure during angiography and angioplasty procedures. The firm will be headed by the former president of Boston's oncology business, Dave McClellan, who will take up the role as Navilyst's president. The chairman and CEO will be Avista's healthcare industry advisor, Ron Sparks.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041385

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel